Sigilon Therapeutics Appoints Kavita Patel, M.D., to Its Board of Directors
June 16, 2020 at 04:30 pm IST
Sigilon Therapeutics, Inc. announced the appointment of Kavita Patel, M.D., to its Board of Directors. Dr. Patel, a practicing physician, has been a leading voice in health policy development and patient-centered care and delivery systems. Dr. Patel is a Nonresident Fellow at the Brookings Institution. Previously, she served as the Managing Director of Clinical Transformation at the Center for Health Policy at Brookings and Vice President of Payer and Provider Strategy at Johns Hopkins Health System.